Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

被引：1
|
作者：
Siontis, Konstantinos C. [1 ]
Zhang, Xiaosong [4 ]
Schaubel, Douglas E. [5 ]
Yao, Xiaoxi [2 ,3 ]
Noseworthy, Peter A. [1 ,2 ]
Shah, Nilay D. [2 ,3 ]
Saran, Rajiv [4 ,6 ]
Nallamothu, Brahmajee K. [7 ,8 ]
机构：
[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
[2] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Del, Rochester, MN USA
[3] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA
[4] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Sch Publ Hlth, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA
[7] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
来源：
CIRCULATION | 2019年 / 139卷 / 12期
关键词：
D O I：
10.1161/CIRCULATIONAHA.118.039290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1563 / 1564
页数：2
相关论文
共 50 条
  • [1] Letter by Cheen Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"
    Cheen, McVin Hua Heng
    [J]. CIRCULATION, 2019, 139 (12) : 1561 - 1562
  • [2] Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
    Siontis, Konstantinos C.
    Zhang, Xiaosong
    Eckard, Ashley
    Bhave, Nicole
    Schaubel, Douglas E.
    He, Kevin
    Tilea, Anca
    Stack, Austin G.
    Balkrishnan, Rajesh
    Yao, Xiaoxi
    Noseworthy, Peter A.
    Shah, Nilay D.
    Saran, Rajiv
    Nallamothu, Brahmajee K.
    [J]. CIRCULATION, 2018, 138 (15) : 1519 - 1529
  • [3] Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States (vol 138, pg 1519, 2018)
    Siontis
    [J]. CIRCULATION, 2018, 138 (15) : E425 - E425
  • [4] Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial"
    Vazquez, Eduardo
    Vazquez-Sanchez, Teresa
    Sanchez-Perales, Carmen
    [J]. CIRCULATION, 2023, 148 (04) : 378 - 378
  • [5] APIXABAN FOR STROKE PREVENTION IN END-STAGE KIDNEY DISEASE PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
    Abdullah, Hafez M.
    Ullah, Waqas
    Jafar, Munnam
    Gowda, Smitha Narayana
    Alraies, M. Chadi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 514 - 514
  • [6] Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
    Watanabe, Hiroshi
    Minamino, Tohru
    [J]. INTERNAL MEDICINE, 2018, 57 (16) : 2285 - 2286
  • [7] Atrial fibrillation associated hospitalizations in patients with end-stage renal disease in the United States, 2003-2012
    Kumar, Nilay
    Khera, Rohan
    Garg, Neetika
    [J]. HEART RHYTHM, 2016, 13 (10) : 2027 - 2033
  • [8] Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation
    Muzio, Sofia
    Artaza, Gonzalo
    Benitez Hidalgo, Olga
    Cortina, Vicente
    Campoy, Desiree
    Beas, Francisco
    Bosch, Marc
    Serra, Marina
    Bosch, Francesc
    Olivera, Pavel E.
    [J]. BLOOD, 2023, 142
  • [9] Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned
    Benz, Alexander P. P.
    Eikelboom, John W. W.
    [J]. CIRCULATION, 2022, 146 (23) : 1746 - 1748
  • [10] Outcomes Associated With Rivaroxaban in Asians With End-stage Renal Disease and Atrial Fibrillation
    Lin, Yi-Cheng
    Chien, Li-Nien
    Chen, Liying
    Chen, Bi-Li
    Fang, Te-Chao
    Huang, Chun-Yao
    [J]. CIRCULATION, 2019, 140
12345